The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

TOP NEWS: Croda International backs full-year outlook on good trading

Fri, 20th May 2022 08:49

(Alliance News) - Croda International PLC on Friday backed its full-year forecasts following a strong start to 2022 which saw the firm "successfully" mitigate inflation pressures.

The Yorkshire, England-based chemicals maker recorded continued sales and profit growth across the business and said it has continued to recover significant input cost inflation.

Demand was particularly strong in North America and Asia, the FTSE 100 listed firm noted.

"Notably, April sales in China were ahead of the prior year despite local Covid-19 lockdowns," it said.

By division, the Consumer Care unit saw robust demand, Croda said,while there was also "good growth" in Beauty Actives, Beauty Care, Home Care, and Fragrances & Flavours.

Croda explained that Fragrances & Flavours specifically benefited from integration synergies and the recent acquisition of Parfex SA. This is a Grasse, France-based fragrance business Croda acquired in April for a total enterprise value of EUR45 million.

Croda also registered growth in its Life Sciences division, which benefited from strong market conditions in crop protection and capacity expansion across Croda's health care platforms, it said.

As a result, Croda left its full-year expectations unchanged.

Croda said that the planned disposal of the majority of its Performance Technologies and Industrial Chemicals businesses is continuing "to plan". The firm expects these to complete this summer.

The potential sale of Croda Sipo in China continues to be explored with its joint venture partner, it said.

In December, Croda agreed to sell the majority of its PTIC businesses to Cargill Inc for an enterprise value of EUR915 million on a cash-free, debt-free basis. Croda noted back then that the price of EUR915 million includes 100% of the Sipo joint venture. If the sale of 100% of Sipo cannot be achieved, it will be excluded from the deal, reducing the purchase price by EUR140 million. The disposals are part of its strategy to transition into a focused Life Sciences and Consumer Care company.

Croda International shares were trading 4.0% higher at 6,812.00 pence each in London on Friday morning.

By Abby Amoakuh; abbyamoakuh@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

Related Shares

More News
24 Apr 2024 15:09

London close: Stocks finish weaker after earlier gains

(Sharecast News) - London markets closed the day weaker on Wednesday, reversing earlier gains as Wall Street stocks opened lower, although mining stoc...

24 Apr 2024 11:55

LONDON MARKET MIDDAY: Investors shake off pre-US inflation nerves

(Alliance News) - The FTSE 100 in London was higher at midday on Wednesday, as investors look ahead to the US Federal Reserve's next test on Friday.

24 Apr 2024 07:50

Croda backs FY profit guidance even as Q1 sales decline

(Sharecast News) - Croda backed its full-year profit guidance on Wednesday despite a decline in first-quarter sales, as it hailed an "encouraging" sta...

24 Apr 2024 07:42

LONDON BRIEFING: Lloyds profit takes hit; Jet2 cuts guidance

(Alliance News) - Stocks in London are set to open higher on Wednesday, as the release of some key US data edges closer

17 Apr 2024 13:59

UK shareholder meetings calendar - next 7 days

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.